Eight months after the U.S. Supreme Court overturned Roe vs. Wade, a federal Trump-appointed judge in Texas is now weighing a lawsuit that could further restrict abortion access nationwide.
“What we’re most concerned about is this decision could take mifepristone off the market completely and that would really impact access to abortion nationwide," said Melissa Reed, CEO and president of Planned Parenthood Keystone.
Mifepristone is the first of a two-pill regimen that accounts for more than half of all abortions in the U.S.
The drug was FDA-approved in 2000.
According to Planned Parenthood, it has been prescribed to over five million women since then.
“This is a very significant and terrible precedent with them being able to take a drug, a very safe drug, off the market, that has been used widely for over 20 years," explained Reed.
Directors at the Pennsylvania Pro-Life Federation believe the drug hasn’t been properly vetted.
“People don’t realize the abortion pill is dangerous, there can be infections, there can be hemorrhaging," said Maria Gallagher, legislative director of the Pennsylvania Pro-Life Federation. "People think this is like taking a Tylenol and it’s not.”
Since the reversal of Roe, more than a dozen states have moved to outlaw abortion.
Read more here: [ Ссылка ]
WPMT-FOX43's YouTube channel is a hub for the best of FOX43 News and its investigative reports, top headlines, and digital exclusive content: youtube.com/c/fox43 SUBSCRIBE: youtube.com/c/fox43
